Rui-Juan Sun

Gemtuzumab Ozogamicin-Containing Salvage Strategies as a Bridge to Second Allogeneic Hematopoietic Stem Cell Transplantation in Post-Transplant Relapsed AML.

GO-containing individualized salvage strategies were associated with manageable hepatic toxicity and feasible bridging to 2nd allo-HSCT, and achieving deep remission before transplantation may be critical for improving post-transplant outcomes.